Vancomycin-resistant enterococci (VRE) in hospital settings across European borders: a scoping review comparing the epidemiology in the Netherlands and Germany.
Antibiotic resistance
Dutch-German cross-border region
Epidemiology
Germany
Prevalence
The Netherlands
VRE
Vancomycin-resistant enterococci
Journal
Antimicrobial resistance and infection control
ISSN: 2047-2994
Titre abrégé: Antimicrob Resist Infect Control
Pays: England
ID NLM: 101585411
Informations de publication
Date de publication:
12 08 2023
12 08 2023
Historique:
received:
12
05
2023
accepted:
19
07
2023
medline:
14
8
2023
pubmed:
12
8
2023
entrez:
11
8
2023
Statut:
epublish
Résumé
The rising prevalence of vancomycin-resistant enterococci (VRE) is a matter of concern in hospital settings across Europe without a distinct geographical pattern. In this scoping review, we compared the epidemiology of vancomycin-resistant Enterococcus spp. in hospitals in the Netherlands and Germany, between 1991 and 2022. We searched PubMed and summarized the national antibiotic resistance surveillance data of the two countries. We included 46 studies and summarized national surveillance data from the NethMap in the Netherlands, the National Antimicrobial Resistance Surveillance database in Germany, and the EARS-Net data. In total, 12 studies were conducted in hospitals in the Netherlands, 32 were conducted in German hospitals, and an additional two studies were conducted in a cross-border setting. The most significant difference between the two countries was that studies in Germany showed an increasing trend in the prevalence of VRE in hospitals, and no such trend was observed in studies in the Netherlands. Furthermore, in both Dutch and German hospitals, it has been revealed that the molecular epidemiology of VREfm has shifted from a predominance of vanA towards vanB over the years. According to national surveillance reports, vancomycin resistance in Enterococcus faecium clinical isolates fluctuates below 1% in Dutch hospitals, whereas it follows an increasing trend in German hospitals (above 20%), as supported by individual studies. This review demonstrates that VRE is more frequently encountered in German than in Dutch hospitals and discusses the underlying factors for the difference in VRE occurrence in these two neighboring countries by comparing differences in healthcare systems, infection prevention control (IPC) guidelines, and antibiotic use in the Netherlands and Germany.
Identifiants
pubmed: 37568229
doi: 10.1186/s13756-023-01278-0
pii: 10.1186/s13756-023-01278-0
pmc: PMC10422769
doi:
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
78Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Curr Opin Microbiol. 2022 Feb;65:73-80
pubmed: 34768106
Euro Surveill. 2022 Feb;27(5):
pubmed: 35115078
Microb Drug Resist. 2005 Summer;11(2):154-8
pubmed: 15910230
J Hosp Infect. 2016 Nov;94(3):236-241
pubmed: 27645212
Clin Infect Dis. 2006 Mar 15;42(6):739-46
pubmed: 16477546
Int J Hyg Environ Health. 2004 Sep;207(4):386-9
pubmed: 15471103
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Nov;58(11-12):1306-13
pubmed: 26391097
Antimicrob Resist Infect Control. 2016 Sep 22;5:31
pubmed: 27688876
Int J Med Microbiol. 2013 Dec;303(8):405-9
pubmed: 23770266
Int J Environ Res Public Health. 2020 Mar 30;17(7):
pubmed: 32235650
Drug Resist Updat. 2020 Dec;53:100732
pubmed: 33189998
J Glob Antimicrob Resist. 2020 Sep;22:102-105
pubmed: 32092477
Antimicrob Resist Infect Control. 2022 Mar 12;11(1):48
pubmed: 35279207
GMS Krankenhhyg Interdiszip. 2011;6(1):Doc20
pubmed: 22242101
J Glob Antimicrob Resist. 2020 Sep;22:646-650
pubmed: 32439568
J Clin Microbiol. 2016 Oct;54(10):2436-47
pubmed: 27147728
Arch Intern Med. 2002 Oct 28;162(19):2223-8
pubmed: 12390066
Antimicrob Agents Chemother. 2002 Jun;46(6):1619-28
pubmed: 12019066
Epidemiol Infect. 2008 Aug;136(8):1131-3
pubmed: 17892630
Ann Intern Med. 2001 Aug 7;135(3):175-83
pubmed: 11487484
Infect Control Hosp Epidemiol. 2000 Aug;21(8):520-4
pubmed: 10968718
FEMS Immunol Med Microbiol. 2008 Apr;52(3):297-308
pubmed: 18279340
BMC Infect Dis. 2016 Sep 02;16:467
pubmed: 27590879
J Antimicrob Chemother. 2018 Dec 1;73(12):3259-3267
pubmed: 30219855
Biol Blood Marrow Transplant. 2007 May;13(5):615-21
pubmed: 17448922
Euro Surveill. 2008 Nov 20;13(47):
pubmed: 19021959
Neth J Med. 2015 May;73(4):169-74
pubmed: 25968288
Int J Med Microbiol. 2013 Aug;303(6-7):360-79
pubmed: 23602510
Microorganisms. 2022 Nov 16;10(11):
pubmed: 36422343
J Antimicrob Chemother. 2020 Oct 1;75(10):2743-2751
pubmed: 32699884
Gesundheitswesen. 2011 Nov;73(11):744-7
pubmed: 22113383
Am J Infect Control. 2019 Jan;47(1):13-17
pubmed: 30268592
J Med Microbiol. 2011 Jul;60(Pt 7):945-949
pubmed: 21459908
Virulence. 2012 Aug 15;3(5):421-33
pubmed: 23076243
Microorganisms. 2022 Aug 09;10(8):
pubmed: 36014021
J Hosp Infect. 2009 Nov;73(3):239-45
pubmed: 19804919
Biol Blood Marrow Transplant. 2017 Feb;23(2):340-346
pubmed: 27890428
J Antimicrob Chemother. 2021 Jun 18;76(7):1698-1702
pubmed: 33855441
Drug Resist Updat. 2018 Sep;40:25-39
pubmed: 30447411
PLoS One. 2020 Jun 24;15(6):e0235160
pubmed: 32579600
Clin Infect Dis. 2005 Aug 1;41(3):327-33
pubmed: 16007529
Gesundheitswesen. 2021 Sep;83(8-09):624-631
pubmed: 32380560
Microbiol Spectr. 2021 Oct 31;9(2):e0035621
pubmed: 34523992
Antibiotics (Basel). 2023 Mar 29;12(4):
pubmed: 37107028
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Oct;61(10):1310-1361
pubmed: 30229318
Antimicrob Resist Infect Control. 2017 Sep 13;6:95
pubmed: 28924472
Ned Tijdschr Geneeskd. 2000 Dec 30;144(53):2568-72
pubmed: 11191795
Ann Clin Microbiol Antimicrob. 2004 Jul 29;3:14
pubmed: 15283864
GMS Hyg Infect Control. 2021 Jan 29;16:Doc06
pubmed: 33643773
Antimicrob Resist Infect Control. 2015 Feb 27;4:7
pubmed: 25763183
Onkologie. 2005 Apr;28(4):187-92
pubmed: 15840966
Infect Control Hosp Epidemiol. 2012 Jul;33(7):718-24
pubmed: 22669234
Trop Med Infect Dis. 2021 Jan 26;6(1):
pubmed: 33530494
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Antimicrob Resist Infect Control. 2016 Apr 18;5:14
pubmed: 27096086
Antimicrob Resist Infect Control. 2018 Apr 24;7:54
pubmed: 29760912
J Antimicrob Chemother. 2014 Jun;69(6):1660-4
pubmed: 24615816
Clin Microbiol Rev. 2019 Jan 30;32(2):
pubmed: 30700430
Lancet. 1988 Jan 2-9;1(8575-6):57-8
pubmed: 2891921
Clin Microbiol Infect. 2008 Aug;14(8):747-54
pubmed: 18727798
Antimicrob Resist Infect Control. 2019 Jul 22;8:123
pubmed: 31367344
Eur J Clin Microbiol Infect Dis. 1991 Jan;10(1):32-4
pubmed: 2009875
Antimicrob Resist Infect Control. 2021 Feb 18;10(1):38
pubmed: 33602300
J Hosp Infect. 1999 Jul;42(3):193-200
pubmed: 10439991
GMS Hyg Infect Control. 2013 Apr 29;8(1):Doc12
pubmed: 23967398
Antimicrob Agents Chemother. 1993 Aug;37(8):1563-71
pubmed: 8215264
Br J Haematol. 2002 Mar;116(4):826-33
pubmed: 11886387
Lancet Infect Dis. 2018 Mar;18(3):318-327
pubmed: 29276051
Infection. 2011 Dec;39(6):501-6
pubmed: 21710119
Antimicrob Agents Chemother. 2019 Apr 25;63(5):
pubmed: 30782988
Lancet Infect Dis. 2001 Dec;1(5):314-25
pubmed: 11871804
Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6908-13
pubmed: 10359812
J Hosp Infect. 2021 May;111:132-139
pubmed: 33582200
Int J Hyg Environ Health. 2000 Oct;203(2):147-52
pubmed: 11109567
J Hosp Infect. 2018 Dec;100(4):e216-e225
pubmed: 29475013
Microorganisms. 2022 Jan 08;10(1):
pubmed: 35056579
J Hosp Infect. 2007 Sep;67(1):49-55
pubmed: 17669548
Dtsch Arztebl Int. 2017 Dec 15;114(50):858-865
pubmed: 29271345
Antimicrob Resist Infect Control. 2018 Nov 14;7:133
pubmed: 30459945
Infect Control Hosp Epidemiol. 2003 Sep;24(9):690-8
pubmed: 14510253
J Glob Antimicrob Resist. 2015 Jun;3(2):128-131
pubmed: 27873661
Open Forum Infect Dis. 2016 Dec 07;4(1):ofw246
pubmed: 28480243
Antimicrob Resist Infect Control. 2020 Aug 10;9(1):130
pubmed: 32778149
Euro Surveill. 2022 Jan;27(2):
pubmed: 35027104
Front Microbiol. 2021 Sep 27;12:728356
pubmed: 34646248
Curr Opin Microbiol. 2013 Feb;16(1):10-6
pubmed: 23395351
J Antimicrob Chemother. 2008 May;61(5):1182-3
pubmed: 18285315
J Antimicrob Chemother. 2019 Oct 1;74(10):2926-2929
pubmed: 31335935
N Engl J Med. 1988 Jul 21;319(3):157-61
pubmed: 2968517
J Hosp Infect. 2019 Mar;101(3):264-271
pubmed: 30408504
Front Microbiol. 2017 Oct 05;8:1914
pubmed: 29051750
Infection. 2012 Dec;40(6):613-9
pubmed: 22665143